Medical Devices US

US Hypertension Management Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Hypertension Management Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.47 Bn Placeholder estimate
Estimate 2025 $1.56 Bn 38.2% of the global market
Projected 2034 $2.63 Bn 68.9% Adds $1.07 Bn over 9 forecast years
CAGR 2025–2034 6.0% Faster than 43% of 173 Medical Devices markets here
Key players 5
  • US is 38.16% of the global market.
  • In North America, the largest is US (this report) at $1.56 Bn.
  • Fastest growing: Canada at 7.6% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.07 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Hypertension Management Devices Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.47 Bn — —
2025 (base) $1.56 Bn +$88.2 Mn —
2026 (forecast) $1.65 Bn +$93.5 Mn +6%
2027 (forecast) $1.75 Bn +$99.1 Mn +12.4%
2028 (forecast) $1.86 Bn +$105.0 Mn +19.1%
2029 (forecast) $1.97 Bn +$111.3 Mn +26.2%
2030 (forecast) $2.08 Bn +$118.0 Mn +33.8%
2031 (forecast) $2.21 Bn +$125.1 Mn +41.9%
2032 (forecast) $2.34 Bn +$132.6 Mn +50.4%
2033 (forecast) $2.48 Bn +$140.5 Mn +59.4%
2034 (forecast) $2.63 Bn +$149.0 Mn +68.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Hypertension Management Devices Market Analysis at a glance
Market size, 2025$1.56 Bn placeholder estimate
Forecast, 2034$2.63 Bn placeholder estimate
Growth (CAGR), 2025–20346.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, channel and end user (see all)
Key playersOmron Healthcare, Withings, A&D Medical, Microlife, Medtronic (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Hypertension Management Devices Market Analysis Executive Summary

Hypertension management devices include home blood pressure monitors, connected cuffs and new procedures that help control high blood pressure.

Key segments of the hypertension Management Devices market include product (Home Blood Pressure Monitors, Connected Monitors and Ambulatory Monitors) and channel (Retail, Online and Clinics).

Bar chart: US Hypertension Management Devices market size, 2024–2034, placeholder estimates. $1.47 Bn in 2024, $1.56 Bn in 2025 and $2.63 Bn in 2034, 6.0% CAGR.
US Hypertension Management Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Hypertension Management Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the hypertension Management Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the hypertension Management Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the hypertension Management Devices market.

Competitive Landscape for Hypertension Management Devices Market in US

The hypertension Management Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hypertension Management Devices Market in US

Hypertension Management Devices in the US: rules, payment and health figures

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2] High blood pressure (ages 30–79): 31.6% of adults 30–79 in 2019, the latest WHO figure for the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hypertension Management Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hypertension Management Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hypertension Management Devices in context

The US compared

  • High blood pressure (ages 30–79): 31.6% of adults 30–79 (2019). World: 33.1% of adults 30–79 (2019).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hypertension Management Devices market in the US?
Placeholder estimate: about $1.56 Bn in 2025, rising to about $2.63 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hypertension Management Devices market in the US growing?
Placeholder estimate: about 6.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hypertension Management Devices market report cover?
The report splits the market by product (Home Blood Pressure Monitors, Connected Monitors, Ambulatory Monitors, Renal Denervation), channel (Retail, Online, Clinics) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hypertension Management Devices market?
Key players include Omron Healthcare, Withings, A&D Medical, Microlife and Medtronic.
What is driving the Hypertension Management Devices market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the hypertension Management Devices market.
Who regulates Hypertension Management Devices in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
What does WHO report for the US?
High blood pressure (ages 30–79): 31.6% of adults 30–79 in 2019, the latest WHO figure. Source: WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 15 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
How much research is published on Hypertension Management Devices?
PubMed lists 158 papers on Hypertension Management Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on hypertension and remote monitoring and wearables

See the topic